» Articles » PMID: 9053845

Suppression of the Malignant Phenotype of Human Glioma Cells by Overexpression of Manganese Superoxide Dismutase

Overview
Journal Oncogene
Date 1997 Jan 30
PMID 9053845
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Manganese superoxide dismutase (MnSOD) has been previously shown to suppress the malignant phenotype of human melanoma and breast cancer cells. To test the possible role of MnSOD in glioma malignancy, MnSOD was overexpressed in wild type human glioma U118 cells and subcloned U118-9 cells by transfection of human MnSOD cDNA. The MnSOD-transfected cell lines demonstrated expression of exogenous (plasmid) MnSOD mRNA, increase in MnSOD immunoreactive protein, and a three- to eightfold increase in MnSOD enzymatic activity. The MnSOD overexpressing cell lines became less malignant as demonstrated by requiring a higher serum concentration to grow in vitro and much slower tumor growth in nude mice than the parental and neo control cell lines. These findings further support the hypothesis that MnSOD may be a tumor suppressor gene in a wide variety of human tumors.

Citing Articles

6-Gingerol Induced Apoptosis and Cell Cycle Arrest in Glioma Cells via MnSOD and ERK Phosphorylation Modulation.

Lim S, Chen W, Ko H, Su Y, Wu C, Huang F Biomol Ther (Seoul). 2024; 33(1):129-142.

PMID: 39632791 PMC: 11704400. DOI: 10.4062/biomolther.2024.084.


Dose-Dependent Effect of Mitochondrial Superoxide Dismutase Gene Overexpression on Radioresistance of HEK293T Cells.

Tavleeva M, Rasova E, Rybak A, Belykh E, Fefilova E, Pnachina E Int J Mol Sci. 2023; 24(24).

PMID: 38139144 PMC: 10744337. DOI: 10.3390/ijms242417315.


Mitochondrial superoxide dismutase Sod2 suppresses nuclear genome instability during oxidative stress.

Gupta S, Campos L, Schmidt K Genetics. 2023; 225(2).

PMID: 37638880 PMC: 10550321. DOI: 10.1093/genetics/iyad147.


Effects of Antioxidant Gene Overexpression on Stress Resistance and Malignization In Vitro and In Vivo: A Review.

Tavleeva M, Belykh E, Rybak A, Rasova E, Chernykh A, Ismailov Z Antioxidants (Basel). 2022; 11(12).

PMID: 36552527 PMC: 9774954. DOI: 10.3390/antiox11122316.


, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression.

Alateyah N, Gupta I, Rusyniak R, Ouhtit A Molecules. 2022; 27(3).

PMID: 35164076 PMC: 8839817. DOI: 10.3390/molecules27030811.